Apellis Pharmaceuticals
(NASDAQ:APLS)
$49.79
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$49.79
PreMarket: 4:01PM EDT
Day Range- - -52 Wk Range33.32 - 70Open / Close- / -Float / Outstanding81.8M / 110.6M
Vol / Avg.- / 1.6MMkt Cap5.5BP/E-50d Avg. Price55.2
Div / Yield-Payout Ratio-Total Float81.8MEPS-1.75

Apellis Pharmaceuticals Stock (NASDAQ:APLS), Quotes and News Summary

Apellis Pharmaceuticals Stock (NASDAQ: APLS) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range33.32 - 70Open / Close- / -Float / Outstanding81.8M / 110.6M
Vol / Avg.- / 1.6MMkt Cap5.5BP/E-50d Avg. Price55.2
Div / Yield-Payout Ratio-Total Float81.8MEPS-1.75
Sector: Health Care.Industry: Biotechnology
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-1.450-1.750 -0.3000
REV21.590M22.056M466.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Apellis Pharmaceuticals (APLS) stock?

A

You can purchase shares of Apellis Pharmaceuticals (NASDAQ: APLS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Apellis Pharmaceuticals's (APLS) competitors?

Q

What is the target price for Apellis Pharmaceuticals (APLS) stock?

A

The latest price target for Apellis Pharmaceuticals (NASDAQ: APLS) was reported by JP Morgan on Tuesday, November 15, 2022. The analyst firm set a price target for 79.00 expecting APLS to rise to within 12 months (a possible 58.67% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Apellis Pharmaceuticals (APLS)?

A

The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $49.79 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Apellis Pharmaceuticals (APLS) pay a dividend?

A

There are no upcoming dividends for Apellis Pharmaceuticals.

Q

When is Apellis Pharmaceuticals (NASDAQ:APLS) reporting earnings?

A

Apellis Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Apellis Pharmaceuticals (APLS) going to split?

A

There is no upcoming split for Apellis Pharmaceuticals.

Q

What sector and industry does Apellis Pharmaceuticals (APLS) operate in?

A

Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.